Mark Hillman's Hillman Value Fund: Focus on Healthcare and Materials
Mark A. Hillman's Hillman Value Fund, as of March 31, 2026, maintains a concentrated portfolio heavily weighted towards Healthcare and Basic Materials sectors.
Portfolio Overview
The Hillman Value Fund, managed by Mark A. Hillman, held a total portfolio value of $144,004,744 as of March 31, 2026. The fund's strategy appears focused on specific sectors, with significant allocations to Healthcare and Basic Materials.
Top Holdings by Value
The fund's largest individual positions, representing the highest value holdings, are:
- Warner Bros Discovery Inc (WBD) - Communication Services sector, valued at $5,390,645 (3.74% of portfolio)
- BioGen Inc (BIIB) - Healthcare sector, valued at $5,415,568 (3.76% of portfolio)
- GSK PLC (GSK) - Healthcare sector, valued at $5,377,272 (3.73% of portfolio)
High Sector Concentration
The fund exhibits strong concentration in the Healthcare sector, with several significant holdings:
- BioGen Inc (BIIB) - 3.76%
- GSK PLC (GSK) - 3.73%
- Pfizer Inc (PFE) - 3.66%
- Zimmer Biomet Holdings Inc (ZBH) - 3.50%
- CVS Health Corp (CVS) - 3.36%
Additionally, the Basic Materials sector is well-represented:
- Dupont de Nemours Inc (DD) - 3.75%
- International Flavors & Fragrances Inc (IFF) - 3.67%
Recent Changes in Holdings
The fund experienced notable changes in its holdings during the prior period:
- Warner Bros Discovery Inc (WBD) saw a significant reduction in shares (-40.64%), likely due to its large allocation.
- BioGen Inc (BIIB) also decreased in shares (-22.98%), though slightly less than WBD.
- GSK PLC (GSK) experienced a substantial decrease (-31.28%) in shares.
- In contrast, Zimmer Biomet Holdings Inc (ZBH) increased in shares (+5.46%), a relatively small gain.
- Carmax Inc (KMX) showed a strong increase (+19.34%) in shares.
Investment Strategy Analysis
The portfolio's structure suggests a value-oriented approach focused on established companies across specific sectors. The fund holds a diverse set of ten stocks, but with significant weight concentrated in Healthcare and Basic Materials. The top holdings indicate exposure to large-cap entities in these sectors. The strategy appears to favor companies with strong fundamentals and potential for steady value appreciation, while avoiding broad market diversification. The fund's performance will likely be influenced by the performance of its highly concentrated Healthcare and Basic Materials holdings, as well as the specific changes observed in several key positions.